Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

The stock of Eli Lilly and Company LLY has declined 1.7% already this week, losing almost $14 billion of its market value.

The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...

Lilly has been solidly investing in research and development (R&D) throughout 2024. In April, the company announced the ...

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

Weight loss medications such as Ozempic may be able to cut drug and alcohol abuse in half, according to a new study from the ...

The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

A new diagnosis of Alzheimer's or other dementia often spurs a person to move from their home, new research shows.

Democrat Wesley Harris and Republican Brad Briner are vying to be the state’s next treasurer, overseeing the management of ...

You’ve probably heard of the semaglutide brand names Ozempic®, Wegovy, and Rybelsus. You may have even heard about affordable options like compounded semaglutide.

The logic suggested by the Lilly trial is the opposite, however. It proposes that being overweight is a primary cause of ...